Radiopharmaceuticals for nuclear medicine patients

Closed Solicitation Posted

Not the latest version. See the latest special notice from .

Solicitation number
36C26026Q0055
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Seattle, Washington, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 is soliciting quotes for radiopharmaceuticals for nuclear medicine patients through Request for Quote 36C26026Q0055. The solicitation seeks a responsible offeror capable of supplying approximately 40 different radiopharmaceutical products, including Technetium-99m compounds, Iodine-123, Iodine-131, Gallium-67, Indium-111, and other specialized nuclear medicine isotopes for diagnostic and therapeutic applications. Key contract requirements include precise dose calibration at requested dates and times, ranging from 5mCi to 30mCi for diagnostic studies and up to 150mCi for therapy studies, with replacement doses provided at no charge in cases of weather delays or patient cancellations. Vendors must provide complete documentation of quality control results and comply with all federal and state regulatory agency requirements. The award will be made based on the vendor's capability to meet all technical specifications and provide the full range of listed radiopharmaceuticals, with quotes due by November 4, 2025, at 1:00 PM PST.

This procurement is structured as a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract with no set-aside designations, covering five ordering periods from January 1, 2026, through December 31, 2030. The solicitation does not identify any incumbent contractors or budget ranges in the available documentation, though the Item Price List specifies estimated quantities for each product across the five ordering periods, ranging from single doses of specialized compounds to volumes of 1,000–2,000 doses for commonly used radiopharmaceuticals. The place of performance is Seattle, Washington, where the VA Puget Sound Health Care System will receive deliveries of the radiopharmaceutical doses. The contract will support nuclear medicine diagnostic imaging and therapeutic treatment for Veterans Health Administration patients throughout the service network region. Vendors should note that compliance with quality control standards and timely delivery capabilities are critical evaluation factors for contract award.

Notice text

Radiopharmaceuticals for nuclear medicine patients.

Files

File Type Posted
S02 36C26026Q0055.docx DOCX document
Item Price List.xlsx XLSX spreadsheet

Notice history

Notice Type Posted
Radiopharmaceuticals for nuclear medicine patients Latest special notice Special Notice
This notice Original Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside
H365--460-27-1-132-0001 | SPE 49273 | VISN 4 Radiation Safety Officer (RSO) | NCO 4 Services 3 (VA-27-00003148) 9 VA Medical Facilities In the NCO 4 Service Area · NAICS 541380 Veterans Integrated Service Network 4 Service-Disabled Veteran-Owned Small Business
6525--SEP 2026 Equipment Only Consolidation NAICS 334517 National Acquisition Center No set-aside
Solicitation for subscription to software for pathology laboratory medicine services. Walla Walla, Washington 99362, United States · NAICS 513210 Veterans Integrated Service Network 20 No set-aside
Microbiological media purchase order for Clinical Microbiology laboratory. Seattle, Washington 98108, United States · NAICS 325998 Veterans Integrated Service Network 20 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors